Fecal marker variability in colorectal cancer: Calprotectin versus hemoglobin

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 10, 1996, Pages 1001-1005

  Gilbert, J A ^a   Ahlquist, D A ^a   Mahoney, D W ^a   Zinsmeister, A R ^a   Rubin, J ^a   Ellefson, R D ^a  

^a MAYO CLINIC   (United States)

Author keywords

calprotectin; colorectal cancer screening; HemoQuant; occult bleeding; stool markers

Indexed keywords

CALPROTECTIN; HEMOGLOBIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; HUMAN; HUMAN TISSUE; OCCULT BLOOD; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

EID: 0029846527     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609003120     Document Type: Article

References (20)

1. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests. JAMA 1993;269:1262-7.
2. Bang KM, Tillet S, Noar SK, Blair A, McDougall V. Sensitivity of fecal Hemoccult testing and flexible sigmoidoscopy for colorectal cancer screening. J Occup Med 1986;28:709-13.
3. Jahn H, Joergensen OK, Kronborg O, Fenger C. Can Hemoccult II replace colonoscopy after radical surgery for colorectal cancer or after polypectomy? Dis Colon Rectum 1992;35:253-6.
4. Rozen P. Screening for colorectal neoplasia in the Tel Aviv area: cumulative data 1979-1989 and initial conclusions. Isr J Med Sci 1992;28:8-20.
5. Ahlquist DA, McGill DB, Fleming JL, Schwartz S, Wieand HS, Rubin J, et al. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer 1989;63:1826-30.
6. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leukocyte L1 protein, calprotectin. Lancet 1990;336:763-5.
7. Brandtzaeg P, Dale I, Fagerhol MK. Distribution of a formalinresistant myelomonocytic antigen (L1) in human tissues. Am J Clin Pathol 1987;87:700-7.
8. Røseth AG, Kristinsson J, Fagerhol MK, Schjønsby H, Aadland E, Nygaard K, et al. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 1993;28: 1073-6.
9. Ahlquist DA, Schwartz S, Isaacson J, Ellefson RD. A stool collection device: the first step in occult blood testing. Ann Intern Med 1988;108:609-12.
10. Schwartz S, Dahl J, Ellefson M, Ahlquist D. The 'HemoQuant' test: a specific and quantitative determination of heme (hemoglobin) in feces and other materials. Clin Chem 1983;29: 2061-7.
11. Ellefson RD, Larson MS, Schwartz S, Ahlquist DA. The HemoQuant test remodeled for the busy clinical laboratory. Clin Chem 1986;32:1142-3.
12. Roseth AG, Fagerhol MK, Schjønsby AH. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992;27:793-8.
13. Ahlquist DA, McGill DB, Schwartz S, Taylor WF, Owen RA. Fecal blood levels in health and disease: a study using HemoQuant. N Engl J Med 1985;312:1422-8.
14. Macrae FA, St. John DJB. Relationship between patterns of bleeding and hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982;82:891.
15. 51Cr method and chemical tests in patients referred for colonoscopy. Scand J Gastroenterol 1984;19: 245-54.
16. 111In-labeled white blood cell. Scand Eur J Nucl Med 1985;11:283-5.
17. 111 indium granulocytes in colonic carcinoma Br J Radiol 1986;59:773-7.
18. Roseth AG, Kristinsson J, Aadland E, Schjonsby J, Nygaard K, Fagerhol MK. Calprotectin: a sensitive marker of gastrointestinal neoplasia. Gastroenterology 1993;104:A390.
19. Ahlquist DA, McGill DB, Schwartz S, Taylor WF, Ellefson M, Owen RA. HemoQuant, a new quantitative assay for fecal hemoglobin: comparison with hemoccult. Ann Intern Med 1984; 101:297-302.
20. Ahlquist DA. Approach to the patient with occult gastrointestinal bleeding. In: Yamada T, editor. Textbook of gastroenterology. 2nd. ed. Philadelphia: J.B. Lippincott, 1995;699-717.